Ethical issues in therapeutic use and research in pregnant and breastfeeding women
Open Access
- 14 May 2021
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 88 (1) , 7-21
Abstract
Pregnant or potentially pregnant women have historically been excluded from clinical trials of new medications. However, it is increasingly recognised that it is imperative to generate evidence from the population in whom the drugs are likely to be used to inform safe, evidence‐based shared clinical decision making. Reluctance by researchers and regulators to perform such studies often relates to concerns about risk, particularly to the foetus. However, this must be offset against the risk of untreated disease or using a drug in pregnancy where safety, efficacy and dosing information are not known. This review summarises the historical perspective, and the ethical and legal frameworks that inform the conduct of such research, then highlights examples of innovative practice that have enabled high quality, ethical research to proceed to inform the evidence‐based use of medication in pregnancy.Keywords
All Related Versions
Funding Information
- Wellcome Trust (222075/Z/20/Z)
This publication has 69 references indexed in Scilit:
- Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in TanzaniaBMC Public Health, 2013
- Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With RifabutinJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countriesAIDS, 2012
- Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settingsBMC Pregnancy and Childbirth, 2012
- Statins and PregnancyDrugs, 2012
- Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008American Journal of Obstetrics and Gynecology, 2011
- A Framework for Incorporating Dyads in Models of HIV-PreventionAIDS and Behavior, 2010
- Optimal Design of Pharmacokinetic StudiesBasic & Clinical Pharmacology & Toxicology, 2010
- Risk of congenital anomalies in pregnant users of statin drugsBritish Journal of Clinical Pharmacology, 2007
- The Use of Population Pharmacokinetics in Drug DevelopmentClinical Pharmacokinetics, 1996